MX2015013158A - Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos. - Google Patents
Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos.Info
- Publication number
- MX2015013158A MX2015013158A MX2015013158A MX2015013158A MX2015013158A MX 2015013158 A MX2015013158 A MX 2015013158A MX 2015013158 A MX2015013158 A MX 2015013158A MX 2015013158 A MX2015013158 A MX 2015013158A MX 2015013158 A MX2015013158 A MX 2015013158A
- Authority
- MX
- Mexico
- Prior art keywords
- bioavailability
- dietary supplement
- products
- enhancing drug
- enhancing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe el mejoramiento de la biodisponibilidad de un fármaco suplemento dietético mediante administración de éste concurrentemente con uno o más miembros de la familia de la d-tetrandrina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361792700P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/024592 WO2014150935A1 (en) | 2013-03-15 | 2014-03-12 | Method and products for enhancing drug and dietary supplement bioavailability |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015013158A true MX2015013158A (es) | 2016-04-15 |
Family
ID=51529972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013158A MX2015013158A (es) | 2013-03-15 | 2014-03-12 | Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US9345257B2 (es) |
EP (1) | EP2986122A4 (es) |
JP (1) | JP2016514142A (es) |
KR (1) | KR20150143504A (es) |
CN (1) | CN105357966A (es) |
MX (1) | MX2015013158A (es) |
WO (1) | WO2014150935A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9345257B2 (en) | 2013-03-15 | 2016-05-24 | Cba Pharma, Inc. | Method and products for enhancing drug and dietary supplement bioavailability |
MX2015013160A (es) * | 2013-03-15 | 2016-04-04 | Cba Pharma Inc | Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911454B1 (en) * | 1989-09-28 | 2005-06-28 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant disease |
US6086915A (en) | 1998-04-01 | 2000-07-11 | Bioresponse L.L.C. | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
US7799802B2 (en) * | 2004-08-03 | 2010-09-21 | Institstute of Oriental Medical Science Inc. | Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation |
US9345257B2 (en) | 2013-03-15 | 2016-05-24 | Cba Pharma, Inc. | Method and products for enhancing drug and dietary supplement bioavailability |
MX2015013160A (es) * | 2013-03-15 | 2016-04-04 | Cba Pharma Inc | Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos. |
-
2014
- 2014-03-12 US US14/206,633 patent/US9345257B2/en active Active
- 2014-03-12 JP JP2016501583A patent/JP2016514142A/ja active Pending
- 2014-03-12 CN CN201480028482.XA patent/CN105357966A/zh active Pending
- 2014-03-12 KR KR1020157029730A patent/KR20150143504A/ko not_active Application Discontinuation
- 2014-03-12 EP EP14767625.8A patent/EP2986122A4/en not_active Withdrawn
- 2014-03-12 MX MX2015013158A patent/MX2015013158A/es unknown
- 2014-03-12 WO PCT/US2014/024592 patent/WO2014150935A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2986122A4 (en) | 2017-01-18 |
EP2986122A1 (en) | 2016-02-24 |
CN105357966A (zh) | 2016-02-24 |
KR20150143504A (ko) | 2015-12-23 |
WO2014150935A1 (en) | 2014-09-25 |
US20140275140A1 (en) | 2014-09-18 |
JP2016514142A (ja) | 2016-05-19 |
US9345257B2 (en) | 2016-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208015A1 (en) | Packaging system for oxygen-sensitive drugs | |
HK1245168A1 (zh) | 配給藥品用的裝置 | |
EP3228298A4 (en) | Medicine bottle | |
EP4005604B8 (en) | Delivery of drugs | |
EP3220961C0 (en) | THERAPEUTIC VITAMIN D CONJUGATES | |
EP3182953A4 (en) | Medication packaging and dose regimen system | |
EP3263155A4 (en) | Drug solution administering device | |
ZA201507576B (en) | Pharmaceutical combination drug | |
PT3024755T (pt) | Cápsula para produtos de infusão | |
EP3008651A4 (en) | Cross-store licensing for third party products | |
EP3183187A4 (en) | Medication packaging and dose regimen system | |
BR112015002123A2 (pt) | conjunto de infusão para uma máquina para a preparação de bebidas utilizando cápsulas e similares | |
TWI800759B (zh) | 醫藥劑型 | |
EP3378493A4 (en) | NOVEL NANOPREPARATION OF ANTICANCER DRUG AND PREPARATION METHOD THEREOF | |
PH12016500847A1 (en) | Multi-particulate drug delivery system | |
EP3351286A4 (en) | DEVICE FOR THE ADMINISTRATION OF A MEDICAMENT SOLUTION | |
MA40447A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
EP3137088A4 (en) | Pharmaceutical packaging for estriol therapy | |
EP3046556A4 (en) | Combination drug therapy | |
MX2015013158A (es) | Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos. | |
EP3154558A4 (en) | Dietary supplement | |
PT3044124T (pt) | Cápsula para produtos de infusão | |
EP3006033A4 (en) | Anticancer drug | |
PH12015500468B1 (en) | Treatment and prevention of acne | |
EP3038655A4 (en) | Method and products for enhancing cellular uptake of drug and dietary supplements |